Literature DB >> 10949916

Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble.

L I Karpenko1, V A Ivanisenko, I A Pika, N A Chikaev, A M Eroshkin, T A Veremeiko, A A Ilyichev.   

Abstract

Hepatitis B core antigen is one of the most promising protein carriers of foreign epitopes of various human and animal pathogens. Chimeric HBcAg particles can be used as effective artificial immunogenes. Unfortunately, not all chimeric proteins are able to be particulated. The dependence of correct or incorrect folding of chimeric proteins on physical and chemical properties of inserts was studied with the help of ProAnalyst, SALIX and QSARPro computer programs. We have found that insertion of amino acids with high hydrophobicity, large volume, and high beta-strand index prevent self-assembling chimeric proteins. These factors are most important for the C-termini of inserts. Recommendations for obtaining correct folding of chimeric HBcAg particles have been given.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949916     DOI: 10.1007/s007260070072

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  14 in total

Review 1.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

2.  Combinatorial approach to hepadnavirus-like particle vaccine design.

Authors:  Jean-Noel Billaud; Darrell Peterson; Margaret Barr; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  The method of noncovalent in vitro binding of target proteins to virus-like nanoparticles formed by core antigen of hepatitis B virus.

Authors:  E A Blokhina; V V Kupriyanov; N V Ravin; K G Skryabin
Journal:  Dokl Biochem Biophys       Date:  2013-03-13       Impact factor: 0.788

Review 4.  Use of hepadnavirus core proteins as vaccine platforms.

Authors:  David C Whitacre; Byung O Lee; David R Milich
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

5.  Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  Ambika Mosale Venkatesh Murthy; Yanyan Ni; Xiangjin Meng; Chenming Zhang
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

6.  An N-terminal extension to the hepatitis B virus core protein forms a poorly ordered trimeric spike in assembled virus-like particles.

Authors:  Richard McGonigle; Wei Boon Yap; Swee Tin Ong; Derek Gatherer; Saskia E Bakker; Wen Siang Tan; David Bhella
Journal:  J Struct Biol       Date:  2014-12-31       Impact factor: 2.867

7.  Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.

Authors:  Izzat Fahimuddin Bin Mohamed Suffian; Julie Tzu-Wen Wang; Naomi O Hodgins; Rebecca Klippstein; Mitla Garcia-Maya; Paul Brown; Yuya Nishimura; Hamed Heidari; Sara Bals; Jane K Sosabowski; Chiaki Ogino; Akihiko Kondo; Khuloud T Al-Jamal
Journal:  Biomaterials       Date:  2016-12-14       Impact factor: 12.479

8.  Ensembles of Hydrophobicity Scales as Potent Classifiers for Chimeric Virus-Like Particle Solubility - An Amino Acid Sequence-Based Machine Learning Approach.

Authors:  Philipp Vormittag; Thorsten Klamp; Jürgen Hubbuch
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05

9.  Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.

Authors:  Bingyang Zhang; Shuang Yin; Yingli Wang; Zhiguo Su; Jingxiu Bi
Journal:  Eng Life Sci       Date:  2021-05-03       Impact factor: 2.678

10.  Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.

Authors:  Upasana Arora; Poornima Tyagi; Sathyamangalam Swaminathan; Navin Khanna
Journal:  J Nanobiotechnology       Date:  2012-07-13       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.